RxPG News Feed for RxPG News

Medical Research Health Special Topics World
 Asian Health
 Food & Nutrition
 Men's Health
 Mental Health
 Occupational Health
 Public Health
 Sleep Hygiene
 Women's Health
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 World Healthcare
   Latest Research
 Alternative Medicine
 Clinical Trials
 Infectious Diseases
 Sports Medicine
   Medical News
 Awards & Prizes
   Special Topics
 Odd Medical News

Last Updated: Oct 11, 2012 - 10:22:56 PM
Osteoporosis Channel

subscribe to Osteoporosis newsletter
Latest Research : Orthopedics : Osteoporosis

   EMAIL   |   PRINT
Modifying NFATc1 Triggers Bone Production

Oct 8, 2006 - 4:48:00 PM , Reviewed by: Himanshu Tyagi
The researchers found that they could tip the balance by modifying the structure of a protein called NFATc1.

[RxPG] Scientists in the US have found a way to trigger bone production, raising hopes of treatment for osteoporosis in humans.

Gerald Crabtree and colleagues at the Howard Hughes Medical Institute, Maryland, found that they could massively increase bone mass in mice by tweaking the structure of a protein in the body.

Osteoporosis is a disease in which bones become fragile and are prone to fractures.

In vertebrates, bone is constantly being formed and broken down throughout life. Cells called osteoclasts continuously degrade bone while cells called osteoblasts replenish it, reported the online edition of BBC News.

In an ideal situation, the two types of cells are perfectly balanced, allowing the bone to maintain bone mass. However, if the balance is upset and more bone is destroyed than formed it can lead to osteoporosis.

The researchers found that they could tip the balance by modifying the structure of a protein called NFATc1.

They modified NFATc1 in mice so it could move more easily into the command centre of cells, and thus become a little more active than usual. This triggered the production of large amounts of new bone, the researchers said.

'It could potentially be possible to develop new drugs to treat osteoporosis by recreating the same effect,' Crabtree said.

The researchers are hopeful that the risk of side effects would be minimal because only small modifications to NFATc1 were required to produce a profound effect.

Publication: Indo Asian News Service

Advertise in this space for $10 per month. Contact us today.

Related Osteoporosis News
Annual treatment with Zoledronic acid significantly reduces bone fractures
Stomach drugs may weaken bones
Modifying NFATc1 Triggers Bone Production
'Magic formula' accurately predicts fracture risk in osteoporotic women
Calcium supplements fail to prevent bone fractures in children
Estrens might not be the answer for osteoporosis
Increasing NFATc1 activity causes massive bone accumulation
Second-Hand Smoke, First-Hand Problem
Low carbohydrate diet did not increase bone loss
Growing body of research links lead to osteoporosis

Subscribe to Osteoporosis Newsletter

Enter your email address:

For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

Contact us

RxPG Online



    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)